Developer docs
API playgroundTry for free, no card

Search company profiles

iSpecimen

Full company profile

uuid0000dbv

Namestring
iSpecimen
Legal namestring
iSpecimen Inc.
Websiteurl
ispecimen.com
Company typeenum
Public
Founded yearint
2014
Descriptiontext

iSpecimen (Nasdaq: ISPC) operates an online two-sided marketplace for human biospecimens, connecting life sciences researchers in pharmaceutical, biotechnology, in vitro diagnostics (IVD), and academic organizations with a global network of 250+ healthcare provider suppliers. The platform, headquartered in Woburn, Massachusetts, is built on AWS and offers pre-screened, mutation-characterized DNA/RNA-sequenced tumor tissue, fresh and preserved biofluids, IVD validation kits, and services for matched sets and prospective collections. Automated de-identification, HIPAA / GDPR / 45 CFR 46 / IRB / IEC compliance, and a Preferred Provider of Cancer Biospecimens designation anchor its regulatory positioning.

Short descriptiontext

iSpecimen operates a Nasdaq-listed (ISPC) two-sided online marketplace for human biospecimens, connecting pharma, biotech, IVD, and academic researchers with 250+ global healthcare provider suppliers. The platform offers AI-driven inventory matching, pre-screened tumor tissue, and prospective collection services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLexington, United States
HQ citystring
Lexington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
human biospecimens marketplace, clinical specimen procurement, biofluids and tissue samples, IVD validation testing kits, biorepository supplier network
Industry5 codes
PRIMARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Medical and Diagnostic Laboratories6215
  • Testing Laboratories and Services541380
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Biospecimen Marketplace
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Marketplace transaction fees on biospecimen sales
TypeMarketplace Commission
Description

iSpecimen generates revenue by taking a margin/commission on biospecimen transactions facilitated through the iSpecimen Marketplace® between researcher buyers and healthcare provider suppliers. Healthcare providers receive a sustainable revenue stream from remnant, banked, or prospectively collected samples sold via the platform.

ispecimen.com
2Custom specimen procurement and project services
TypeProfessional Services
Description

Revenue from custom specimen procurement, prospective collection projects, study design services, sample kitting and logistics, lab services, and biospecimen data management for researchers whose needs exceed off-the-shelf banked inventory. Includes project-based fees for matched-set, liquid biopsy, and rare-disease cohort builds.

ispecimen.com
3IVD validation testing kit sales
TypeOne Time License
Description

Revenue from customizable, launch-ready validation testing kits containing clinically-characterized samples or diagnostic reference specimens sold to in-vitro diagnostics (IVD) companies to support onboarding of new diagnostic tests and instrument systems.

ispecimen.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations, Others
Pricing details2 tiers
1Quote-based pricing for all biospecimens and services; no public price list
ModelOther
Notes

Researcher-facing Request a Quote form; pricing varies by specimen type, disease state, volume, annotations, collection method, and shipping logistics. Quote-based; pricing model not publicly disclosed. Customer testimonial notes 'revamped, competitive pricing structure' for fresh whole blood.

ispecimen.com
2Custom discounts for large or repeat orders
ModelOther
Notes

No standard volume deals; open to negotiated pricing for large orders. Negotiable case-by-case.

ispecimen.com
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Brand1 of 3 records shown
1iSpecimen Marketplace
Description

The company's flagship online marketplace platform (registered as iSpecimen Marketplace®) that connects life science researchers with healthcare biospecimen providers for streamlined procurement of human biospecimens.

ispecimen.com
+2 more records
Core offering1 text field

iSpecimen operates an online global marketplace that connects life science researchers with a network of 250+ healthcare provider organizations to procure human biospecimens (biofluids, tissue, and cells) for research, drug discovery, and diagnostic test validation. The company takes a margin on each marketplace transaction, provides custom and prospective specimen procurement services, and sells ready-to-use validation testing kits for IVD companies. All transactions are processed under a unified contract with integrated compliance (HIPAA, GDPR, IRB/IEC).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Over 80% of researchers report limiting studies due to insufficient biospecimen quantities — iSpecimen's marketplace addresses this access gap.
+6 more records
Product overview1 text field

iSpecimen operates a single integrated platform-plus-modules architecture anchored on the iSpecimen Marketplace, an Amazon-like online global marketplace that connects life science researchers needing human biospecimens with a network of healthcare providers and biorepositories. The Marketplace is powered by the SalesStack digital transformation platform, which delivered end-to-end system integration, legacy data migration, and live production activation in its Milestone 2, and which embeds AI-driven matching capabilities including the internally developed AI-powered Inventory Agent (an LLM-powered conversational agent that extracts request criteria and ranks inventory matches). On top of the core marketplace, iSpecimen sells sub-product specimen categories — Human Biofluids (whole blood, serum & plasma, buffy coats, swabs, urine, stool, CSF, saliva, sputum), Human Tissue Samples (fresh, fresh frozen, FFPE, tissue microarrays, DNA & RNA sequenced cancer tissue, matched sets), Stem and Immune Cells (leukopaks, mobilized leukopaks, bone marrow aspirate, PBMCs, BMMCs), Validation Testing Kits (IVD), and Matched Biospecimen Sets — supported by service offerings (Specimen Procurement, Study Design, Sample Kits and Logistics, Biospecimen Data & Data Management, Lab Services), partner-facing programs such as the Marketplace Onsite Program, and operational enhancements such as the Open Feasibilities Dashboard and the Direct Shipping Model. Together, these products, sub-categories, and services compose a unified biospecimen procurement ecosystem with AI-augmented matching and a single contracting interface across hundreds of supplier organizations.

Product and service14 records
1iSpecimen Marketplace
CategoryCore platform
2Human Biofluids
CategoryBiospecimen product category
3Human Tissue Samples
CategoryBiospecimen product category
4Stem and Immune Cells
CategoryBiospecimen product category
5Matched Biospecimen Sets
CategoryBiospecimen product category
6Validation Testing Kits (IVD)
CategoryBiospecimen product category
7DNA and RNA Sequenced Cancer Tissue
8Specimen Procurement Services
CategoryService offering
9Study Design Services
CategoryService offering
10Sample Kits and Logistics
CategoryService offering
11Biospecimen Data and Data Management
CategoryService offering
12Lab Services
CategoryService offering
13Marketplace Onsite Program
CategoryService offering / partner program
14Direct Shipping Model
CategoryService offering / logistics model
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierMajor Blood-Center AllianceTypeStrategic or Co-development Partner
Description

Listed on iSpecimen's Industry Alliances page as a partner, indicating a relationship with the major U.S. blood center to support blood-product biospecimen supply through the iSpecimen Marketplace.

Strategic tierTechnology Integration PartnerTypeTechnology or Integration
Description

Agilent's SLIMS laboratory information management system is referenced as an Industry Alliance partner, supporting integration between biospecimen provider labs and the iSpecimen Marketplace platform.

Strategic tierMarketplace PartnerTypeGTM or Marketing Partner
Description

Science Exchange listed as an Industry Alliance partner, extending iSpecimen's reach into a broader outsourced research services marketplace.

Strategic tierMarketplace PartnerTypeGTM or Marketing Partner
Description

Scientist.com listed as an Industry Alliance partner, connecting iSpecimen's biospecimen supply with Scientist.com's research-services procurement platform.

Strategic tierIndustry Association PartnerTypeOthers
Description

Listed as an Industry Alliance partner supporting clinical research professional education and biospecimen sourcing awareness.

6Pathology Informatics (pathologyinformatics.org)
Strategic tierIndustry Association PartnerTypeOthers
Description

Listed as an Industry Alliance partner supporting pathology informatics standards relevant to biospecimen data management.

ispecimen.com
7International Society for Biological and Environmental Repositories (ISBER)
Strategic tierIndustry Association PartnerTypeOthers
Description

Listed as an Industry Alliance partner; iSpecimen presented new research at the ISBER 2022 Annual Meeting in Atlanta.

ispecimen.com
Strategic tierRegional Biotech Industry PartnerTypeOthers
Description

Listed as an Industry Alliance partner supporting the Massachusetts biotech ecosystem.

Strategic tierTrade Media PartnerTypeGTM or Marketing Partner
Description

Listed as an Industry Alliance partner, providing exposure in the clinical laboratory and blood-banking trade media space.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global supplier of human biospecimens (including acquired Tissue Solutions) serving pharma, biotech, diagnostics, and academic researchers with a multi-supplier network. Directly comparable as a competing biospecimen procurement marketplace and catalog.

TypeDirect peer
Description

Biospecimen procurement and sample management services company offering characterized biospecimens, custom collections, and biobanking across multiple disease states. Competes directly with iSpecimen's marketplace in pharma and biotech accounts.

TypeDirect peer
Description

Clinical biospecimen CRO with biorepository and prospective collection capabilities spanning oncology, infectious disease, and women's health. Closely comparable in customer base (pharma/biotech) and biospecimen procurement service model.

TypeBroad incumbent
Description

Global life sciences manufacturer with a large bioscience segment offering primary cells, hematopoietic products, and biospecimens. Overlaps with iSpecimen's stem and immune cell offerings and serves similar pharma/biotech customers as part of a much broader portfolio.

TypeBroad incumbent
Description

Major CRO offering biospecimen and research services alongside preclinical and clinical offerings. Competes for pharma biospecimen procurement budgets as part of a much wider services portfolio.

TypeBroad incumbent
Description

Non-profit biological resource center providing authenticated cell lines, microbial materials, and biospecimens. Comparable as a supplier of characterized research specimens to academic and biopharma customers, though focused on catalog rather than prospective collections.

TypeEmerging player
Description

Specialty provider of cell culture media, cell separation products, and primary cells (PBMCs, hematopoietic products). Comparable in stem and immune cell product lines that overlap with iSpecimen's hematologic specimen offerings.

TypeDirect peer
Description

Biospecimen supplier specializing in human tissue samples including FFPE, frozen, and fresh tissue with annotated clinical data. Comparable in tissue-focused biospecimen offerings to pharma and academic oncology researchers.

TypeDirect peer
Description

Provider of tissue and biofluid biospecimens, RNA/DNA extracted products, and tissue microarrays. Comparable in catalog tissue and biospecimen offerings targeting pharma and academic research customers.

TypeOthers
Description

Outsourced research services marketplace connecting biopharma researchers with service providers. Listed as an iSpecimen Industry Alliance partner and is adjacent in the research procurement marketplace category.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iSpecimen

Biospecimen Marketplaceispecimen.com

iSpecimen operates a Nasdaq-listed (ISPC) two-sided online marketplace for human biospecimens, connecting pharma, biotech, IVD, and academic researchers with 250+ global healthcare provider suppliers. The platform offers AI-driven inventory matching, pre-screened tumor tissue, and prospective collection services.

What iSpecimen does

iSpecimen (Nasdaq: ISPC) operates an online two-sided marketplace for human biospecimens, connecting life sciences researchers in pharmaceutical, biotechnology, in vitro diagnostics (IVD), and academic organizations with a global network of 250+ healthcare provider suppliers. The platform, headquartered in Woburn, Massachusetts, is built on AWS and offers pre-screened, mutation-characterized DNA/RNA-sequenced tumor tissue, fresh and preserved biofluids, IVD validation kits, and services for matched sets and prospective collections. Automated de-identification, HIPAA / GDPR / 45 CFR 46 / IRB / IEC compliance, and a Preferred Provider of Cancer Biospecimens designation anchor its regulatory positioning.

iSpecimen firmographics

Firmographics
Name
iSpecimen
Legal name
iSpecimen Inc.
Website
https://ispecimen.com
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
iSpecimen operates a Nasdaq-listed (ISPC) two-sided online marketplace for human biospecimens, connecting pharma, biotech, IVD, and academic researchers with 250+ global healthcare provider suppliers. The platform offers AI-driven inventory matching, pre-screened tumor tissue, and prospective collection services.
Ownership category
akta.pro rank

iSpecimen industry classification

Industry
Product category
Biospecimen Marketplace
NAICS
Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (541380)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)

Keywords

  • Human biospecimens marketplace
  • Clinical specimen procurement
  • Biofluids and tissue samples
  • IVD validation testing kits
  • Biorepository supplier network

Where iSpecimen is headquartered

Location

Headquarters

HQ city
Lexington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

iSpecimen business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations, Others

Revenue model

  1. Marketplace transaction fees on biospecimen sales: iSpecimen generates revenue by taking a margin/commission on biospecimen transactions facilitated through the iSpecimen Marketplace® between researcher buyers and healthcare provider suppliers. Healthcare providers receive a sustainable revenue stream from remnant, banked, or prospectively collected samples sold via the platform.
  2. Custom specimen procurement and project services: Revenue from custom specimen procurement, prospective collection projects, study design services, sample kitting and logistics, lab services, and biospecimen data management for researchers whose needs exceed off-the-shelf banked inventory. Includes project-based fees for matched-set, liquid biopsy, and rare-disease cohort builds.
  3. IVD validation testing kit sales: Revenue from customizable, launch-ready validation testing kits containing clinically-characterized samples or diagnostic reference specimens sold to in-vitro diagnostics (IVD) companies to support onboarding of new diagnostic tests and instrument systems.

Pricing tiers

ModelBillingPrice
Other—Quote-based pricing for all biospecimens and services; no public price list
Other—Custom discounts for large or repeat orders

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

iSpecimen product offering

Product offering

Core offering

iSpecimen operates an online global marketplace that connects life science researchers with a network of 250+ healthcare provider organizations to procure human biospecimens (biofluids, tissue, and cells) for research, drug discovery, and diagnostic test validation. The company takes a margin on each marketplace transaction, provides custom and prospective specimen procurement services, and sells ready-to-use validation testing kits for IVD companies. All transactions are processed under a unified contract with integrated compliance (HIPAA, GDPR, IRB/IEC).

Product overview

iSpecimen operates a single integrated platform-plus-modules architecture anchored on the iSpecimen Marketplace, an Amazon-like online global marketplace that connects life science researchers needing human biospecimens with a network of healthcare providers and biorepositories. The Marketplace is powered by the SalesStack digital transformation platform, which delivered end-to-end system integration, legacy data migration, and live production activation in its Milestone 2, and which embeds AI-driven matching capabilities including the internally developed AI-powered Inventory Agent (an LLM-powered conversational agent that extracts request criteria and ranks inventory matches). On top of the core marketplace, iSpecimen sells sub-product specimen categories — Human Biofluids (whole blood, serum & plasma, buffy coats, swabs, urine, stool, CSF, saliva, sputum), Human Tissue Samples (fresh, fresh frozen, FFPE, tissue microarrays, DNA & RNA sequenced cancer tissue, matched sets), Stem and Immune Cells (leukopaks, mobilized leukopaks, bone marrow aspirate, PBMCs, BMMCs), Validation Testing Kits (IVD), and Matched Biospecimen Sets — supported by service offerings (Specimen Procurement, Study Design, Sample Kits and Logistics, Biospecimen Data & Data Management, Lab Services), partner-facing programs such as the Marketplace Onsite Program, and operational enhancements such as the Open Feasibilities Dashboard and the Direct Shipping Model. Together, these products, sub-categories, and services compose a unified biospecimen procurement ecosystem with AI-augmented matching and a single contracting interface across hundreds of supplier organizations.

Differentiator

Problem solved

Functional benefit

Brands

  • iSpecimen Marketplace: The company's flagship online marketplace platform (registered as iSpecimen Marketplace®) that connects life science researchers with healthcare biospecimen providers for streamlined procurement of human biospecimens.
  • SalesStack
  • Inventory Agent

Products and services

  • iSpecimen Marketplace
  • Human Biofluids
  • Human Tissue Samples
  • Stem and Immune Cells
  • Matched Biospecimen Sets
  • Validation Testing Kits (IVD)
  • DNA and RNA Sequenced Cancer Tissue
  • Specimen Procurement Services
  • Study Design Services
  • Sample Kits and Logistics
  • Biospecimen Data and Data Management
  • Lab Services
  • Marketplace Onsite Program
  • Direct Shipping Model

Quantifiable outcome

  • Over 80% of researchers report limiting studies due to insufficient biospecimen quantities — iSpecimen's marketplace addresses this access gap.
  • +6 more outcomes

Companies that use iSpecimen

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles5 records

iSpecimen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

iSpecimen partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered major blood-center alliance, technology integration partner, marketplace partner, industry association partner, regional biotech industry partner and trade media partner.

  • OneBloodmajor blood-center allianceStrategic or Co-development PartnerListed on iSpecimen's Industry Alliances page as a partner, indicating a relationship with the major U.S. blood center to support blood-product biospecimen supply through the iSpecimen Marketplace.
  • Agilent (Agilent SLIMS)technology integration partnerTechnology or IntegrationAgilent's SLIMS laboratory information management system is referenced as an Industry Alliance partner, supporting integration between biospecimen provider labs and the iSpecimen Marketplace platform.
  • Science Exchangemarketplace partnerGTM or Marketing PartnerScience Exchange listed as an Industry Alliance partner, extending iSpecimen's reach into a broader outsourced research services marketplace.
  • Scientist.commarketplace partnerGTM or Marketing PartnerScientist.com listed as an Industry Alliance partner, connecting iSpecimen's biospecimen supply with Scientist.com's research-services procurement platform.
  • Association of Clinical Research Professionals (ACRP)industry association partnerOthersListed as an Industry Alliance partner supporting clinical research professional education and biospecimen sourcing awareness.
  • Pathology Informatics (pathologyinformatics.org)industry association partnerOthersListed as an Industry Alliance partner supporting pathology informatics standards relevant to biospecimen data management.
  • International Society for Biological and Environmental Repositories (ISBER)industry association partnerOthersListed as an Industry Alliance partner; iSpecimen presented new research at the ISBER 2022 Annual Meeting in Atlanta.
  • MassBio (Massachusetts Biotechnology Council)regional biotech industry partnerOthersListed as an Industry Alliance partner supporting the Massachusetts biotech ecosystem.
  • The Dark Intelligence Group / The Dark Reporttrade media partnerGTM or Marketing PartnerListed as an Industry Alliance partner, providing exposure in the clinical laboratory and blood-banking trade media space.

Scale indicators13 records

Recent moves9 records

Expansion highlights6 records

iSpecimen competitors and assessment

Company assessment

Direct peers

  • BioIVT: Global supplier of human biospecimens (including acquired Tissue Solutions) serving pharma, biotech, diagnostics, and academic researchers with a multi-supplier network. Directly comparable as a competing biospecimen procurement marketplace and catalog.
  • Discovery Life Sciences: Biospecimen procurement and sample management services company offering characterized biospecimens, custom collections, and biobanking across multiple disease states. Competes directly with iSpecimen's marketplace in pharma and biotech accounts.
  • Cureline: Clinical biospecimen CRO with biorepository and prospective collection capabilities spanning oncology, infectious disease, and women's health. Closely comparable in customer base (pharma/biotech) and biospecimen procurement service model.
  • ProteoGenex: Biospecimen supplier specializing in human tissue samples including FFPE, frozen, and fresh tissue with annotated clinical data. Comparable in tissue-focused biospecimen offerings to pharma and academic oncology researchers.
  • BioChain Institute: Provider of tissue and biofluid biospecimens, RNA/DNA extracted products, and tissue microarrays. Comparable in catalog tissue and biospecimen offerings targeting pharma and academic research customers.

Broad incumbents

  • Lonza: Global life sciences manufacturer with a large bioscience segment offering primary cells, hematopoietic products, and biospecimens. Overlaps with iSpecimen's stem and immune cell offerings and serves similar pharma/biotech customers as part of a much broader portfolio.
  • Charles River Laboratories: Major CRO offering biospecimen and research services alongside preclinical and clinical offerings. Competes for pharma biospecimen procurement budgets as part of a much wider services portfolio.
  • ATCC: Non-profit biological resource center providing authenticated cell lines, microbial materials, and biospecimens. Comparable as a supplier of characterized research specimens to academic and biopharma customers, though focused on catalog rather than prospective collections.

Emerging players

  • Stemcell Technologies: Specialty provider of cell culture media, cell separation products, and primary cells (PBMCs, hematopoietic products). Comparable in stem and immune cell product lines that overlap with iSpecimen's hematologic specimen offerings.

Others

  • Scientist.com: Outsourced research services marketplace connecting biopharma researchers with service providers. Listed as an iSpecimen Industry Alliance partner and is adjacent in the research procurement marketplace category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

iSpecimen social profiles

Digital presence

iSpecimen compliance and trust

Trust signal

Compliance3 records

iSpecimen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iSpecimen leadership team

Management profile

Number of profiles

Profiles7 records

iSpecimen funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iSpecimen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iSpecimen

What does iSpecimen do?

iSpecimen operates an online global marketplace that connects life science researchers with a network of 250+ healthcare provider organizations to procure human biospecimens (biofluids, tissue, and cells) for research, drug discovery, and diagnostic test validation. The company takes a margin on each marketplace transaction, provides custom and prospective specimen procurement services, and sells ready-to-use validation testing kits for IVD companies. All transactions are processed under a unified contract with integrated compliance (HIPAA, GDPR, IRB/IEC).

Is iSpecimen a public or private company?

iSpecimen is a public company. It is classified as public and is currently operating.

When was iSpecimen founded?

iSpecimen was founded in 2014. It employs 11 to 50 people.

Where is iSpecimen based?

iSpecimen is headquartered in Lexington, United States, in the North America region.

How does iSpecimen make money?

Three revenue lines are on record. Marketplace transaction fees on biospecimen sales are the primary driver. The others are custom specimen procurement and project services and IVD validation testing kit sales.

Who are iSpecimen's main competitors?

Direct peers on record are BioIVT, Discovery Life Sciences, Cureline, ProteoGenex and BioChain Institute. Broad incumbents are Lonza, Charles River Laboratories and ATCC. Stemcell Technologies is listed as an emerging player. Scientist.com is listed as an others.

Does iSpecimen have an API?

No public API is recorded for iSpecimen.

What industry is iSpecimen in?

iSpecimen's product category is Biospecimen Marketplace. Its primary akta.pro industry code is HLACAOAO, Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AktieniSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI ProductsiSpecimen completed the acquisition of two AI products from Foldlab AI on November 2, 2026, including a protein-identification agent and a disease-trend model. The $4.5 million purchase price includes $750,000 cash, up to $1.25 million in milestones, and 2.9 million shares. The deal expands iSpecimen into AI-powered disease intelligence.Ticker ReportComparing Bullfrog AI (NASDAQ:BFRG) & iSpecimen (NASDAQ:ISPC)Bullfrog AI and iSpecimen are compared on valuation, earnings, and institutional ownership. Bullfrog AI beats iSpecimen on 8 of 12 factors, including lower price-to-earnings ratio and higher earnings. Bullfrog AI has a beta of -2.73, indicating lower volatility than iSpecimen's 1.65.Defense WorldVivoSim Labs (NASDAQ:VIVS) vs. iSpecimen (NASDAQ:ISPC) Head to Head ComparisoniSpecimen and VivoSim Labs are compared on analyst ratings, ownership, profitability, and valuation. iSpecimen beats VivoSim Labs on 9 of 11 factors, with higher revenue and earnings, but VivoSim Labs trades at a lower price-to-earnings ratio.NewsfileiSpecimen Supports Hospital Validation of New Chemistry AnalyzeriSpecimen is supporting a hospital laboratory in validating a new chemistry analyzer by coordinating collection of over 1,700 serum, plasma, CSF, and urine specimens. The specimens cover a broad range of analytes and results, enabling evaluation across specimen types. Specimen collection remains ongoing while iSpecimen manages the project.AktieniSpecimen Supports Hospital Validation of New Chemistry AnalyzeriSpecimen is supporting a hospital laboratory in validating a new chemistry analyzer by coordinating collection of over 1,700 serum, plasma, CSF, and urine specimens. The specimens cover a broad range of analytes and results, enabling performance evaluation across specimen types. Specimen collection remains ongoing while iSpecimen manages the project.FinancialContent Business PageiSpecimen Supports Hospital Validation of New Chemistry AnalyzeriSpecimen is supporting a hospital laboratory in validating a new chemistry analyzer by coordinating collection of over 1,700 serum, plasma, CSF, and urine specimens. The specimens cover a broad range of analytes and results, enabling evaluation across specimen types. Specimen collection remains ongoing while iSpecimen manages the project.Stock TitaniSpecimen Coordinates 1,700+ Specimens for ValidationiSpecimen is coordinating the collection of over 1,700 serum, plasma, CSF, and urine specimens to support a hospital's validation of a new chemistry analyzer. The specimens cover a broad range of analytes and results, enabling performance evaluation across specimen types. The hospital will complete validation before clinical testing, with collection ongoing.BioSpaceiSpecimen Supports Hospital Validation of New Chemistry AnalyzeriSpecimen is coordinating collection of over 1,700 serum, plasma, CSF, and urine specimens for a hospital's validation of a new chemistry analyzer. The specimens cover a broad range of analytes and results, enabling evaluation across specimen types. Collection remains ongoing, with iSpecimen managing the project between the hospital and a healthcare system using the analyzer.Ticker ReportComparing VivoSim Labs (NASDAQ:VIVS) and iSpecimen (NASDAQ:ISPC)iSpecimen beats VivoSim Labs on 9 of 11 factors, including higher revenue and lower price-to-earnings ratio. VivoSim Labs has a beta of 1.45 versus iSpecimen's 1.62, and iSpecimen has higher institutional ownership at 13.6% versus 8.2%.Ticker ReportiSpecimen (NASDAQ:ISPC) & Revvity (NYSE:RVTY) Financial SurveyRevvity and iSpecimen are compared on valuation, profitability, and analyst ratings. Revvity has higher revenue and earnings, while iSpecimen trades at a lower P/E ratio. Analysts favor Revvity, with a consensus target price of $116.57 and 86.7% institutional ownership.